| Authors: |
Krogh NS; ZiteLab ApS, Copenhagen, Denmark. Electronic address: nielssteenkrogh@zitelab.dk., Prieto-Merino D; Faculty of Medicine, University of Alcalá, Alcalá de Henares, Spain., Coker B; Unit for Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom; Research and Development Department, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Birkner T; Center for Evidence-based Healthcare, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Akkoc A; ZiteLab ApS, Copenhagen, Denmark., Gribaleva E; Unit for Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom., Nielsen IV; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Frostrup AG; Pfizer ApS, Ballerup, Denmark., Christensen MO; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Thomsen SF; Department of Dermatology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark., Irvine AD; Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; Dermatology, Children's Health Ireland, Crumlin, Ireland; National Children's Research Centre, Dublin, Ireland., Fletcher G; National and International Skin Registries Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Spuls PI; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Hennessy C; National and International Skin Registries Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Farrell B; National and International Skin Registries Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Jackson A; Pfizer Healthcare Ireland, Dublin, Ireland., Guler E; Pfizer, Istanbul, Turkey., Bruninx E; Pfizer NV/SA, Brussels, Belgium., Cutlar L; National and International Skin Registries Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Gerbens LAA; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Henrohn D; Pfizer AB, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Hyseni A; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., McCarthy C; Pfizer Healthcare Ireland, Dublin, Ireland., Ouwerkerk W; Department of Dermatology, Amsterdam Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Randall R; Pfizer, Tadworth, United Kingdom., Wall D; National and International Skin Registries Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland; Hair Restoration Blackrock, Dublin, Ireland; The Mater Misericordiae University Hospital, Dublin, Ireland., Hertzschuch A; Center for Evidence-based Healthcare, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Germany., Werfel T; Medical School Hannover, Hannover, Germany., Schmitt J; Center for Evidence-based Healthcare, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., Flohr C; Unit for Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, United Kingdom. |
